Skip to main content
Clinical Trials/NCT05884697
NCT05884697Active, not recruitingNot Applicable

Let's K-Talk: A Storytelling Intervention Leveraging Chatbot Technology to Prevent HPV and HPV Associated Cancers for Ethnic Koreans Living in the U.S.

University of Cincinnati1 site in 1 country120 target enrollmentStarted: May 10, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
120
Locations
1
Primary Endpoint
Number of participants who completed 3 doses of HPV vaccines at 12-months

Study Overview

Brief Summary

The goal of this clinical trial is to test the feasibility, acceptability, and preliminary efficacy of a storytelling video-based intervention using AI chatbot technology (K-Talk) to promote HPV vaccination behavior among Korean Americans aged 18 to 45.

The main questions this study aims to answer are:

  • Is the K-Talk intervention feasible for use among Korean Americans aged 18 to 45?
  • Is the K-Talk intervention acceptable to the target population?
  • What is the preliminary efficacy of the K-Talk intervention in promoting HPV vaccination uptake?

Participants will be Korean Americans aged 18 to 45 who are at risk for HPV infection. Participants will be asked to complete a baseline survey and then will be "randomized" into one of four groups: Group 1 (chatbot + storytelling intervention), Group 2 (chatbot only), Group 3 (storytelling only), and Group 4 will be only exposed to written didactic HPV education materials. All groups will receive written didactic HPV education materials. Researchers will compare how Group 1, a combination of AI Chatbot and storytelling intervention is more effective than other intervention groups in promoting HPV vaccination uptake among underserved, hard-to-reach Korean Americans.

Detailed Description

The objective of this study is to conduct a pilot Multiphase Optimization Strategy trial (MOST) to evaluate the acceptability, feasibility, and preliminary efficacy of K-Talk as an intervention to improve HPV vaccination initiation and completion among Korean American men and women. K-Talk is a user-centered intervention that combines AI chatbot technology with storytelling to enhance health communication, foster connection, and provide accurate advice related to HPV vaccination. The study design follows an optimization phase of the MOST, utilizing a 2 x 2 factorial design with two factors (storytelling and chatbot) and two levels (Yes/On and No/Off). The study aims to recruit a total of 160 participants, with 40 participants assigned to each experimental condition. The sample will consist of 80 males and 80 females who are eligible for participation in factorial experimentation using the MOST design. Interested individuals will undergo an online eligibility screening survey. If eligible for the study, participants will receive an online survey link containing informed consent, a baseline survey, written HPV information, and random assignment to an intervention group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

Qualtrics is an online survey software used by researchers. It can randomly assign participants to different groups without revealing the assignments to participants or researchers, blinding them to the assignment. This ensures unbiased treatment and assessment of participants.

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Identify as a Korean ethnic person
  • •Reside in the U.S.
  • •between the ages of 18 and 45
  • •be able to speak or read English
  • •not have been vaccinated against HPV
  • •use a mobile device.

Exclusion Criteria

  • •Participants who do not identify as a Korean ethnic person
  • •Participants who do not reside in the U.S.
  • •Participants who are not between the ages of 18 and
  • •Participants who cannot speak or read English.
  • •Participants who have been vaccinated against HPV.
  • •Participants who do not use a mobile device.

Arms & Interventions

K-Talk Intervention: Storytelling and AI Chatbot

Experimental

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Talk group will receive a series of weekly storytelling videos, and access to the chatbot via the web-based platform KakaoTalk for 3 months.

Intervention: K-Talk Intervention (Storytelling and K-Bot) (Other)

K-Talk Intervention: Storytelling and AI Chatbot

Experimental

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Talk group will receive a series of weekly storytelling videos, and access to the chatbot via the web-based platform KakaoTalk for 3 months.

Intervention: Written Information (Other)

Storytelling Intervention

Experimental

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The storytelling intervention group will only be exposed to periodic release of stories via email for 3 months.

Intervention: Storytelling Intervention (Other)

Storytelling Intervention

Experimental

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The storytelling intervention group will only be exposed to periodic release of stories via email for 3 months.

Intervention: Written Information (Other)

K-Bot (AI Chatbot Intervention) Intervention

Experimental

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Bot group will only interact with the chatbot via the web-based platform or KakaoTalk for 3 months.

Intervention: K-Bot Intervention (Other)

K-Bot (AI Chatbot Intervention) Intervention

Experimental

After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Bot group will only interact with the chatbot via the web-based platform or KakaoTalk for 3 months.

Intervention: Written Information (Other)

Written Information

Active Comparator

This group will only be exposed to written, didactic HPV education materials after the pre-test.

Intervention: Written Information (Other)

Outcomes

Primary Outcomes

Number of participants who completed 3 doses of HPV vaccines at 12-months

Time Frame: 12 months after the baseline

Completion of 3 doses of HPV vaccines

Number of participants who completed 3 doses of HPV vaccines at 6-months

Time Frame: 6 months after the baseline

Completion of 3 doses of HPV vaccines

Number of participants who received at least one dose of HPV vaccine at 6-month

Time Frame: 6-months after the baseline

Participants who received at least one dose of HPV vaccine at 6-month

Number of participants who received at least one dose of HPV vaccine at 12-month

Time Frame: 12-months after the baseline

Participants who received at least one dose of HPV vaccine at 12-month

Number of participants who received at least one dose of HPV vaccine at 3-month

Time Frame: 3-months after the baseline

Participants who received at least one dose of HPV vaccine at 3-month

Secondary Outcomes

  • Assessing Perceived Risk of HPV and Other STIs: A 17-Item Survey (on a 1-5 Likert scale)(at baseline and 3-month follow-up)
  • Assessment of Intention to Receive HPV Vaccine: Two Items Self-Report(at baseline, 3-month, 6-month, and 12-month follow-up)
  • Assessment of Knowledge about HPV and HPV Vaccines: A 34-Item Survey (True/False/I don't know)(at baseline and 3-month follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Minjin Kim

Assistant Professor

University of Cincinnati

Study Sites (1)

Loading locations...

Similar Trials